These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22428064)

  • 1. Local gene silencing of monocyte chemoattractant protein-1 prevents vulnerable plaque disruption in apolipoprotein E-knockout mice.
    Liu XL; Zhang PF; Ding SF; Wang Y; Zhang M; Zhao YX; Ni M; Zhang Y
    PLoS One; 2012; 7(3):e33497. PubMed ID: 22428064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoting plaque stability by gene silencing of monocyte chemotactic protein-3 or overexpression of tissue factor pathway inhibitor in ApoE-/- mice.
    Zhao Y; Chen W; Liu Y; Li H; Chi J; Chang Q; Shen L; Yan R; Li J; Yin X; Fu Y
    J Drug Target; 2021 Jul; 29(6):669-675. PubMed ID: 33472448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial interference of toll-like receptor 2 and 4 synergistically stabilizes atherosclerotic plaque in apolipoprotein E-knockout mice.
    Yang JM; Wang Y; Qi LH; Wang Y; Gao F; Ding SF; Ni M; Liu CX; Zhang C; Zhang Y
    J Cell Mol Med; 2011 Mar; 15(3):602-11. PubMed ID: 20132416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of mTOR by lentivirus‑mediated RNA interference suppresses atherosclerosis and stabilizes plaques via a decrease of macrophages by autophagy in apolipoprotein E‑deficient mice.
    Wang X; Li L; Li M; Dang X; Wan L; Wang N; Bi X; Gu C; Qiu S; Niu X; Zhu X; Wang L
    Int J Mol Med; 2013 Nov; 32(5):1215-21. PubMed ID: 24043133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene profiling in atherosclerosis reveals a key role for small inducible cytokines: validation using a novel monocyte chemoattractant protein monoclonal antibody.
    Lutgens E; Faber B; Schapira K; Evelo CT; van Haaften R; Heeneman S; Cleutjens KB; Bijnens AP; Beckers L; Porter JG; Mackay CR; Rennert P; Bailly V; Jarpe M; Dolinski B; Koteliansky V; de Fougerolles T; Daemen MJ
    Circulation; 2005 Jun; 111(25):3443-52. PubMed ID: 15967845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The impact of cyclophilin A small interfering RNA on the formation of atherosclerotic plaque in apolipoprotein E-deficient mice].
    Yan J; Li Y; Wang C; Yuan W; Wang Z
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Jul; 42(7):593-7. PubMed ID: 25327603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of atherosclerotic lesions in diabetic apolipoprotein E-deficient mice using gene silencing of macrophage migration inhibitory factor.
    Sun H; Zhang X; Zhao L; Zhen X; Huang S; Wang S; He H; Liu Z; Xu N; Yang F; Qu Z; Ma Z; Zhang C; Zhang Y; Hu Q
    J Cell Mol Med; 2015 Apr; 19(4):836-49. PubMed ID: 25661015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced stabilization of atherosclerotic plaques in apolipoprotein E-knockout mice by combinatorial Toll-like receptor-1 and -2 gene silencing.
    Qi LH; Wang Y; Gao F; Zhang C; Ding SF; Ni M; Feng JB; Zhang Y
    Hum Gene Ther; 2009 Jul; 20(7):739-50. PubMed ID: 19278303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTRP9 enhances carotid plaque stability by reducing pro-inflammatory cytokines in macrophages.
    Li J; Zhang P; Li T; Liu Y; Zhu Q; Chen T; Liu T; Huang C; Zhang J; Zhang Y; Guo Y
    Biochem Biophys Res Commun; 2015 Mar; 458(4):890-5. PubMed ID: 25701788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of Non-POU-domain-containing octamer-binding protein stabilizes atherosclerotic plaque in apolipoprotein E-knockout mice via NF-κB signaling pathway.
    Zhang K; Zhang F; Yang JM; Kong J; Meng X; Zhang M; Zhang C; Zhang Y
    Int J Cardiol; 2018 Jul; 263():96-103. PubMed ID: 29673854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. siRNA-mediated silencing of Wnt5a regulates inflammatory responses in atherosclerosis through the MAPK/NF-κB pathways.
    Yang L; Chu Y; Wang Y; Zhao X; Xu W; Zhang P; Liu X; Dong S; He W; Gao C
    Int J Mol Med; 2014 Oct; 34(4):1147-52. PubMed ID: 25050997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of atherosclerosis plaques in apolipoprotein E-/- mice after lentivirus-mediated RNA interference of CD40.
    Wang B; Qian H; Yang H; Xu L; Xu W; Yan J
    Int J Cardiol; 2013 Feb; 163(1):34-9. PubMed ID: 21640399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Green tea polyphenol epigallocatechin-3-gallate increases atherosclerotic plaque stability in apolipoprotein E-deficient mice fed a high-fat diet.
    Wang Q; Zhang J; Li Y; Shi H; Wang H; Chen B; Wang F; Wang Z; Yang Z; Wang L
    Kardiol Pol; 2018; 76(8):1263-1270. PubMed ID: 29862488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice.
    Inoue S; Egashira K; Ni W; Kitamoto S; Usui M; Otani K; Ishibashi M; Hiasa K; Nishida K; Takeshita A
    Circulation; 2002 Nov; 106(21):2700-6. PubMed ID: 12438296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice.
    Eefting D; Bot I; de Vries MR; Schepers A; van Bockel JH; Van Berkel TJ; Biessen EA; Quax PH
    J Vasc Surg; 2009 Jul; 50(1):152-60. PubMed ID: 19563963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary cholesterol oxidation products accelerate plaque destabilization and rupture associated with monocyte infiltration/activation via the MCP-1-CCR2 pathway in mouse brachiocephalic arteries: therapeutic effects of ezetimibe.
    Sato K; Nakano K; Katsuki S; Matoba T; Osada K; Sawamura T; Sunagawa K; Egashira K
    J Atheroscler Thromb; 2012; 19(11):986-98. PubMed ID: 22785139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle-mediated delivery of pitavastatin inhibits atherosclerotic plaque destabilization/rupture in mice by regulating the recruitment of inflammatory monocytes.
    Katsuki S; Matoba T; Nakashiro S; Sato K; Koga J; Nakano K; Nakano Y; Egusa S; Sunagawa K; Egashira K
    Circulation; 2014 Feb; 129(8):896-906. PubMed ID: 24305567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherosclerotic plaque disruption induced by stress and lipopolysaccharide in apolipoprotein E knockout mice.
    Ni M; Wang Y; Zhang M; Zhang PF; Ding SF; Liu CX; Liu XL; Zhao YX; Zhang Y
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1598-606. PubMed ID: 19286965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant-negative mutation of monocyte chemoattractant protein-1 prevents vulnerable plaques from rupture in rabbits independent of serum lipid levels.
    Zhong L; Chen WQ; Ji XP; Zhang M; Zhao YX; Yao GH; Zhang PF; Zhang C; Zhang Y
    J Cell Mol Med; 2008 Dec; 12(6A):2362-71. PubMed ID: 18266972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentiviral-mediated RNA interference of lipoprotein-associated phospholipase A2 ameliorates inflammation and atherosclerosis in apolipoprotein E-deficient mice.
    Zhang H; Zhang J; Shen D; Zhang L; He F; Dang Y; Li L
    Int J Mol Med; 2013 Mar; 31(3):651-9. PubMed ID: 23338278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.